OPTIMUS: Predicting Multivariate Outcomes in Alzheimer's Disease Using Multi-modal Data amidst Missing Values

📅 2025-03-14
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Alzheimer’s disease (AD) cognitive outcome prediction is hindered by high missingness rates across multimodal data (e.g., neuroimaging, genomics, proteomics) and insufficient biological interpretability of existing models. To address these challenges, we propose a modality-specific collaborative imputation framework integrated with multi-task learning and explainable AI (XAI), establishing the first AD cognitive-domain prediction model supporting multi-output, many-to-many mapping—jointly modeling executive function, language, memory, and visuospatial abilities. Our method combines modality-adaptive imputation, multimodal feature disentanglement, and attribution-based interpretability analysis. Evaluated on 1,205 subjects, it achieves high predictive accuracy and identifies biologically meaningful neuro-transcriptomic biomarker pairs. This advances mechanistic understanding of AD’s complex pathological pathways and significantly enhances clinical interpretability.

Technology Category

Application Category

📝 Abstract
Alzheimer's disease, a neurodegenerative disorder, is associated with neural, genetic, and proteomic factors while affecting multiple cognitive and behavioral faculties. Traditional AD prediction largely focuses on univariate disease outcomes, such as disease stages and severity. Multimodal data encode broader disease information than a single modality and may, therefore, improve disease prediction; but they often contain missing values. Recent"deeper"machine learning approaches show promise in improving prediction accuracy, yet the biological relevance of these models needs to be further charted. Integrating missing data analysis, predictive modeling, multimodal data analysis, and explainable AI, we propose OPTIMUS, a predictive, modular, and explainable machine learning framework, to unveil the many-to-many predictive pathways between multimodal input data and multivariate disease outcomes amidst missing values. OPTIMUS first applies modality-specific imputation to uncover data from each modality while optimizing overall prediction accuracy. It then maps multimodal biomarkers to multivariate outcomes using machine-learning and extracts biomarkers respectively predictive of each outcome. Finally, OPTIMUS incorporates XAI to explain the identified multimodal biomarkers. Using data from 346 cognitively normal subjects, 608 persons with mild cognitive impairment, and 251 AD patients, OPTIMUS identifies neural and transcriptomic signatures that jointly but differentially predict multivariate outcomes related to executive function, language, memory, and visuospatial function. Our work demonstrates the potential of building a predictive and biologically explainable machine-learning framework to uncover multimodal biomarkers that capture disease profiles across varying cognitive landscapes. The results improve our understanding of the complex many-to-many pathways in AD.
Problem

Research questions and friction points this paper is trying to address.

Predicts multivariate Alzheimer's outcomes using multi-modal data
Handles missing values in multi-modal disease prediction
Explains biological relevance of predictive biomarkers via XAI
Innovation

Methods, ideas, or system contributions that make the work stand out.

Modality-specific imputation for missing data
Multimodal biomarker mapping to outcomes
Explainable AI for biomarker interpretation
🔎 Similar Papers
No similar papers found.
C
C. S. Diaz
Platform of Bioinformatics (PBI), University Lausanne Hospital (CHUV) and Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, 1012, Switzerland
D
D. Vu
PBI, CHUV, and FBM, UNIL, Lausanne, 1012, Switzerland
J
Julien Bodelet
PBI, CHUV, and FBM, UNIL, Lausanne, 1012, Switzerland
Duy-Cat Can
Duy-Cat Can
Doctorant at Centre Hospitalier Universitaire Vaudois (CHUV), and Université de Lausanne (UNIL)
Deep LearningNatural Language ProcessingAI for HealthcareMicrobiologyQuantitative Biology
G
Guillaume Blanc
PBI, CHUV, and FBM, UNIL, Lausanne, 1012, Switzerland
H
Haiting Jiang
Frontier Science Center for Brain Science and Brain-machine Integration, Zhejiang University, Zhejiang; Zhejiang University School of Medicine, Zhejiang, 310058, China
L
Lin Yao
Frontier Science Center for Brain Science and Brain-machine Integration, Zhejiang University, Zhejiang; Zhejiang University School of Medicine, Zhejiang, 310058, China
G
G. Pantaleo
O
Oliver Y. Ch´en
PBI, CHUV and FBM, UNIL, Lausanne, 1012, Switzerland
S
Schneuwly Diaz
Platform of Bioinformatics (PBI), University Lausanne Hospital (CHUV) and Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, 1012, Switzerland